Latest MIMS bulletin complements monthly product update

MIMS Spotlight is the latest email bulletin from MIMS, designed specifically to complement MIMS Product Update. Each issue draws together the latest MIMS news and prescribing resources for a key therapeutic area.

You can sign up for MIMS Spotlight at www.healthcarerepublic.com/bulletins.

Coinciding with the global year against musculoskeletal pain, the next issue of MIMS Spotlight will highlight major recent drug launches in the musculoskeletal field, including the first therapeutic antibody for osteoporosis and the first new gout treatment for 40 years. Alongside, it will offer a selection of our helpful prescribing resources, including patient fact sheets and drug comparison tables.

MIMS Spotlight is designed to help you:

• choose the right treatments
• follow national guidelines
• support and advise your patients
• keep abreast of emerging medicines.

Topics covered in previous issues of MIMS Spotlight include diabetes, women’s health and digestive disorders. Future issues will collate prescribing news and resources relevant to cardiovascular conditions, respiratory disease and other conditions commonly encountered in primary care.

Make sure you’re getting the most out of MIMS. Visit www.healthcarerepublic.com/bulletins to register for MIMS Spotlight.